EUVIMED · CrossrefZeitschrift
Diabetes & Metabolism
ISSN 1262-3636 · Elsevier BV
Neueste Artikel
Clinical outcomes associated with glucagon-like peptide-1 receptor agonist therapy in patients with peripheral artery disease and diabetes
Beyond glycaemic control: autoimmune polyglandular syndrome type 3 as an emerging distinct entity rather than a mere comorbidity in paediatric type 1 diabetes
Maternal antibody transfer confounds type 1 diabetes screening in infancy: results from the French TRAKR cohort
Interpreting oxygen saturation associations in diabetic neuropathy
Association of quantitative computed tomography–derived hepatic fat with an oral glucose tolerance test–derived insulin clearance surrogate in type 2 diabetes
Magnetic resonance imaging–defined visceral adiposity beyond body mass index is associated with insulin resistance and early glycemic dysregulation in adults without diabetes
Towards a digital twin for precision diabetes care: a phenotypic mapping and virtual representation of a person living with type 1 diabetes in the SFDT1 study
The BCAA paradox: From anabolic nutrients to metabolic signals in insulin resistance
Risk of incident type 2 diabetes with romosozumab versus denosumab in patients with osteoporosis: A global real-world cohort study
Efficacy and safety of the dual SGLT1 and SGLT2 inhibitor JP-2266 in Type 2 Diabetes: a randomized, double-blind, placebo-controlled, phase 2 study (Diabetes Metab J, published online July 29, 2026)
Cognitive leisure activity and incident dementia among older adults with diabetes: a 5-year prospective cohort study
One patient, two glucose profiles: arm-dependent continuous glucose monitoring discordance in hemiplegia
Real-world effectiveness of tirzepatide in individuals with obesity: weight response, treatment-related factors and diabetes status
Gestational diabetes mellitus in women with polycystic ovary syndrome
Advanced automated insulin delivery in inpatients receiving nutritional support: a single-center, open-label, randomised controlled trial
Association between glucagon-like peptide-1 receptor agonists and colorectal cancer survival: A population-based cohort study
Overview of the major clinical trials investigating stem cells–based therapies for diabetes
Reassessing the role of GLP-1 receptor agonists in colorectal cancer Care
GLP-1-derived therapies and sarcopenia: plea for a specific focus on at risk special populations
Ketoacidosis associated with type 2 sodium-glucose cotransporter inhibitors (SGLT2i) in patients aged 65 and older: Evidence from the French national pharmacovigilance database
SGLT2 inhibitors and the risk of hepatocellular carcinoma in patients with MASLD and Type 2 diabetes
Incidence of death and amputation in patients with a first diabetic foot ulcer: results from the CODIA cohort
Mitochondrial heteroplasmy-phenotype correlation and response to glucose lowering therapy in subjects with m.3243A>G mutations
GLP-1 receptor agonists, body composition, skeletal muscle and risk of sarcopaenia: from promising findings in animal models to debated concern in human studies
Post-translational modifications of apolipoproteins as promising biomarkers for diabetes-related cardiovascular diseases: A comprehensive review
Association between continuous glucose monitoring metrics and metabolic dysfunction-associated steatotic liver disease in adults with type 1 diabetes undergoing vibration-controlled transient elastography: a multicenter cross-sectional study
Diabetes prevalence, awareness, and control in the United States, 2017-2023
Global Burden of type 2 diabetes in non-elderly individuals 1990 to 2021 and projections for 2050: a systematic analysis of the 2021 Global Burden of Disease
Glucose management indicator: Do we need device-specific equations?
Practical implementation of automated insulin delivery systems in 2025: A French position statement update
EUVIMED